3,587
Views
42
CrossRef citations to date
0
Altmetric
Review

CAR-T cell therapy and infection: a review

, , , , ORCID Icon & ORCID Icon
Pages 749-758 | Received 27 Sep 2020, Accepted 20 Nov 2020, Published online: 31 Dec 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Tadesse Asmamaw Dejenie, Markeshaw Tiruneh G/Medhin, Gashaw Dessie Terefe, Fitalew Tadele Admasu, Wondwossen Wale Tesega & Endeshaw Chekol Abebe. (2022) Current updates on generations, approvals, and clinical trials of CAR T-cell therapy. Human Vaccines & Immunotherapeutics 18:6.
Read now
David Luque-Paz, Pierre Sesques, Florent Wallet, Emmanuel Bachy & Florence Ader. (2022) The burden of SARS-CoV-2 in patients receiving chimeric antigen receptor T cell immunotherapy: everything to lose. Expert Review of Anti-infective Therapy 20:9, pages 1155-1162.
Read now

Articles from other publishers (40)

Dengqiang Wu & Yujie Li. (2023) Application of adoptive cell therapy in hepatocellular carcinoma. Immunology 170:4, pages 453-469.
Crossref
Rebecca S. Steinberg, Aditi Nayak, Alexis Okoh, Jeffrey Wang, Erin Matiello, Alanna A. Morris, Jennifer A. CowgerAnju Nohria. (2023) Associations Between Preimplant Cancer Type and Left Ventricular Assist Device Outcomes: An INTERMACS Registry Analysis. ASAIO Journal.
Crossref
Marcio Nucci & Elias Anaissie. (2023) Invasive fusariosis. Clinical Microbiology Reviews.
Crossref
Olivia L. Makos & Christopher R. D'Angelo. (2023) The shifting roles and toxicities of cellular therapies in B‐cell malignancies. Transplant Infectious Disease 25:S1.
Crossref
Lora Thomas & Julie Boatman. (2023) Evaluation of pulmonary abnormalities in recipients of hematopoietic cell transplants and cellular therapies. Transplant Infectious Disease 25:S1.
Crossref
Gemma Reynolds, Victoria G. Hall & Benjamin W. Teh. (2023) Vaccine schedule recommendations and updates for patients with hematologic malignancy post‐hematopoietic cell transplant or CAR T‐cell therapy. Transplant Infectious Disease 25:S1.
Crossref
Michelly Abreu, Jaimole Varghese, Minifrida Santiago & Karla Ow. (2023) Cytomegalovirus infection in chimeric antigen receptor T-cell recipients. Journal of the American Association of Nurse Practitioners 35:11, pages 747-750.
Crossref
Matteo Amicucci, Valentina Simioli, Valentina De Cecco, Laura Orlando, Italo Ciaralli, Alessandra Buccino, Barbara Guidi, Giovanna Locatelli, Claudia Palmieri, Martina Piazzalunga, Romina Proietti, Agnese Pucci & Stefano Botti. (2023) Nursing Management in Pediatric Patients Undergoing Chimeric Antigen Receptor T (CAR-T) Cell Therapy: A Systematic Literature Review. Seminars in Oncology Nursing 39:5, pages 151478.
Crossref
Deborah Springell, Maeve O’Reilly & Claire Roddie. (2023) Supportive care for chimeric antigen receptor T-cell patients. Current Opinion in Supportive & Palliative Care 17:3, pages 231-239.
Crossref
Alistair D. Calder, Giulia Perucca, Sarah May Johnson, Ashwin R. Pandey, Karyn Moshal & Maaike A. Kusters. (2023) Lung infections in immunocompromised children. Pediatric Radiology.
Crossref
Rosanne Sprute, Julia A. Nacov, Dionysios Neofytos, Matteo Oliverio, Juergen Prattes, Ilana Reinhold, Oliver A. Cornely & Jannik Stemler. (2023) Antifungal prophylaxis and pre-emptive therapy: When and how?. Molecular Aspects of Medicine 92, pages 101190.
Crossref
Tingting Zhang, Weiwei Tian, Shuang Wei, Xinyi Lu, Jing An, Shaolong He, Jie Zhao, Zhilin Gao, Li Li, Ke Lian, Qiang Zhou, Huilai Zhang, Liang Wang, Liping Su, Huicong Kang, Ting Niu, Ailin Zhao, Jing Pan, Qingqing Cai, Zhenshu Xu, Wenming Chen, Hongmei Jing, Peng Li, Wanhong Zhao, Yang Cao, Jianqing Mi, Tao Chen, Yuan Chen, Ping Zou, Veronika Lukacs-Kornek, Christian Kurts, Jian Li, Xiansheng Liu, Qi Mei, Yicheng Zhang & Jia Wei. (2023) Multidisciplinary recommendations for the management of CAR-T recipients in the post-COVID-19 pandemic era. Experimental Hematology & Oncology 12:1.
Crossref
Zhao Liang, Hong Xu, Xuan Zhou, JiLong Yang, Sanfang Tu, Yanjie He, Lijuan Zhou & Yuhua Li. (2023) Donor-derived CAR-T therapy improves the survival of relapsed B-ALL after allogeneic transplantation compared with donor lymphocyte infusion. Human Cell 36:5, pages 1716-1728.
Crossref
Peiling Zhang, Liang Huang, Miao Zheng, Chao Zhang, Dongyi Wan, Jia Wei & Yang Cao. (2023) Case Report: Active tuberculosis infection in CAR T-cell recipients post CAR T-cell therapy: a retrospective case series. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Gemma Reynolds, Beatrice Sim, Mary Ann Anderson, Tim Spelman, Benjamin W. Teh, Monica A. Slavin & Karin A. Thursky. (2023) Predicting infections in patients with haematological malignancies treated with chimeric antigen receptor T-cell therapies: A systematic scoping review and narrative synthesis. Clinical Microbiology and Infection.
Crossref
Iwona Hus, Agnieszka Szymczyk, Joanna Mańko & Joanna Drozd-Sokołowska. (2023) COVID-19 in Adult Patients with Hematological Malignancies—Lessons Learned after Three Years of Pandemic. Biology 12:4, pages 545.
Crossref
Di Wang, Li He, Chunhui Li, Menglei Xu, Qiuxia Yu, Varlene Daniela Fernandes Almeida, Yimei Que, Yanjie Xu, Yi Xiao & Chunrui Li. (2023) Mutations in immunodeficiency-related genes may increase the risk of infection after CAR-T-cell therapy: a report of two cases. BMC Infectious Diseases 23:1.
Crossref
Dian Zhou, Ying Wang, Hai Cheng, Lili Zhu, Wei Chen, Hujun Li, Xiaotian Zhang, Jieyun Xia, Yuekun Qi, Sha Ma, Feng Zhu, Zhiling Yan, Kunming Qi, Wei Sang, Haiying Sun, Depeng Li, Jiang Cao, Zhenyu Li & Kailin Xu. (2023) Factors associated with infection events after chimeric antigen receptor T-cell therapy for relapsed or refractory multiple myeloma. Journal of Infection and Chemotherapy 29:2, pages 179-185.
Crossref
Juan C. Gea-Banacloche. (2023) Infectious complications of chimeric antigen receptor (CAR) T-cell therapies. Seminars in Hematology 60:1, pages 52-58.
Crossref
Willem J.J. Falkenburg, Marit Jalink, Marie José Kersten, Jochem B. Buil & Karin van Dijk. (2022) Olecranon bursitis caused by Scedosporium apiospermum in a patient treated with CAR-T cells. Medical Mycology Case Reports 38, pages 33-35.
Crossref
Sara H. Keshavjee, Ryan H. Moy, Steven L. Reiner, Sandra W. Ryeom & Sam S. Yoon. (2022) Gastric Cancer and the Immune System: The Key to Improving Outcomes?. Cancers 14:23, pages 5940.
Crossref
Jian Yang, Jinwen Zhang, Jia Wei, Guangjie Wu, Jianxin Song, Dong Liu & Yan He. (2022) Prolonged Duration of Lymphocyte Deficiency, High-grade CRS, and Ventilation Are Linked to Fungal Breakthrough in Patients with Hematologic Malignancies 60 Days after CAR-T Infusion: a Single Center Case-Control Study. Journal of Infection and Public Health.
Crossref
Dong Liu, Yuefeng Hu, Jian Wei, Wen Zhang, Chunmei Piao, Yongcheng Lu, Yue Wang, Jingwei Liu & Xu Lu. (2022) Antibody‐dependent cell‐mediated cytotoxicity using T cells with NK‐like phenotype in combination with avelumab, an anti‐PD‐L1 antibody . Immunology 167:2, pages 212-220.
Crossref
Madeline E. DeWane, Jeffrey S. Smith, Mia S. DeSimone & Arash Mostaghimi. (2022) A case of refractory verrucous varicella zoster virus in a patient with persistent pancytopenia after CAR-T therapy. British Journal of Dermatology 187:3, pages e77-e77.
Crossref
Lei Chen, Ting Xie, Bing Wei & Da-Lin Di. (2022) Current progress in CAR‑T cell therapy for tumor treatment (Review). Oncology Letters 24:4.
Crossref
Yixuan Fang, Boxu Liu & Wenze Song. (2022) CAR-T Therapy: A Promising Cancer Treatment. Highlights in Science, Engineering and Technology 8, pages 100-110.
Crossref
Chenghao Ge, Kelei Du, Mingjie Luo, Kaini Shen, Yangzhong Zhou, Kaiyuan Guo, Yang Liu, Chen Yin, Yi Li, Guanqiao Li & Xiaoyuan Chen. (2022) Serologic response and safety of COVID-19 vaccination in HSCT or CAR T-cell recipients: a systematic review and meta-analysis. Experimental Hematology & Oncology 11:1.
Crossref
Simona Gössi, Ulrike Bacher, Claudia Haslebacher, Michael Nagler, Franziska Suter, Cornelia Staehelin, Urban Novak & Thomas Pabst. (2022) Humoral Responses to Repetitive Doses of COVID-19 mRNA Vaccines in Patients with CAR-T-Cell Therapy. Cancers 14:14, pages 3527.
Crossref
Carlos Grasa, Bárbara Ochoa, Fernando Baquero‐Artigao, Sonsoles San Román, Víctor Galán‐Gómez, Teresa del Rosal, Cristina Calvo & Antonio Pérez‐Martínez. (2022) Disseminated tuberculosis infection in a CAR T‐cell recipient. Pediatric Blood & Cancer 69:7.
Crossref
Keke Fei, Haiqing Ni, Mengjia Zhu, Zhihui Kuang, Min Wu, Zhihai Wu, Feifei Wang, Shuaixiang Zhou, Hua Jing, Weiwei Wu, Dongdong Wu, Dongmei Bai & Bingliang Chen. (2022) IBI379, a novel B cell maturation antigen/CD3 bispecific T-cell engager, displays high antitumor efficacy in preclinical models of multiple myeloma. Cancer Letters 536, pages 215663.
Crossref
Linghui Zhou, Elaine Tan Su Yin, Houli Zhao, Shuyi Ding, Yongxian Hu & He Huang. (2022) Infections in hematologic malignancy patients treated by CD19 chimeric antigen receptor T‐cell therapy. ImmunoMedicine 2:1.
Crossref
Daniel K. Yeoh, Gabrielle M. Haeusler, Brendan J. McMullan, Coen Butters, Penelope A. Bryant, Julia E. Clark, Celia M. Cooper, Amanda Gwee, Rishi S. Kotecha, Tony Lai, Monica A. Slavin, Karin A. Thursky & Christopher C. Blyth. (2022) Antifungal use in children with acute leukaemia: state of current evidence and directions for future research. Journal of Antimicrobial Chemotherapy 77:6, pages 1508-1524.
Crossref
Mohadeseh Mirzaee Godarzee, Bashdar Mahmud Hussen, Ehsan Razmara, Benyamin Hakak‐Zargar, Fatemeh Mohajerani, Hamed Dabiri, Mohammed Fatih Rasul, Mohammad Hossein Ghazimoradi, Sadegh Babashah & Majid Sadeghizadeh. (2022) Strategies to overcome the side effects of chimeric antigen receptor T cell therapy. Annals of the New York Academy of Sciences 1510:1, pages 18-35.
Crossref
Salvatrice Mancuso, Marta Mattana, Melania Carlisi, Marco Santoro & Sergio Siragusa. (2022) Effects of B-Cell Lymphoma on the Immune System and Immune Recovery after Treatment: The Paradigm of Targeted Therapy. International Journal of Molecular Sciences 23:6, pages 3368.
Crossref
Alison Robins, Emma Dishner, Patrick McDaneld, Meagan Rowan, Jalen Bartek, Ying Jiang, Javier Adachi & Natalie J. M. Dailey Garnes. (2021) Improving the safety of outpatient parenteral antimicrobial therapy for patients with solid tumors. Supportive Care in Cancer 30:2, pages 1643-1654.
Crossref
Cheng Zu, Yufeng Xu, Yiyun Wang, Mingming Zhang, Houli Zhao, Xiaoyun Fang, He Huang & Yongxian Hu. (2022) Cytomegalovirus Retinitis and Retinal Detachment following Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory Multiple Myeloma. Current Oncology 29:2, pages 490-496.
Crossref
Justin G. Yoon, Daniel A. Smith, Sree H. Tirumani, Paolo F. Caimi & Nikhil H. Ramaiya. (2021) CAR T-Cell Therapy: An Update for Radiologists. American Journal of Roentgenology 217:6, pages 1461-1474.
Crossref
Yong Liang, Huanle Gong, Yan Li, Yinghao Lu, Xiaoqian Wu, Xiaoyan Zhang, Dan Ding, Xiaolong Tang & Qiyun Tang. (2021) Aggregation-Induced Emission-Based Vaccine Improves Potential Antitumor Immunotherapy. Journal of Biomedical Nanotechnology 17:10, pages 2053-2061.
Crossref
Anthony P. Longhitano, Monica A. Slavin, Simon J. Harrison & Benjamin W. Teh. (2021) Bispecific antibody therapy, its use and risks for infection: Bridging the knowledge gap. Blood Reviews 49, pages 100810.
Crossref
Adam G. Stewart & Andrea S. Henden. (2021) Infectious complications of CAR T-cell therapy: a clinical update. Therapeutic Advances in Infectious Disease 8, pages 204993612110367.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.